Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy
Status:
Completed
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
Breast cancer patients who received docetaxel chemotherapy were randomly divided into two
groups; experimental group: the patients received intravenous infusion of succinylated
gelatin one day before and on the day of chemotherapy, 500ml each time, once per day; control
group: observation. Primary endpoint: total incidence of fluid retention. Secondary
endpoints: severity and duration of fluid retention, change in quality of life score.